1. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system;Chen;Cancer.,2014
2. Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival;Casal-Mourino;Transl. Lung Cancer Res.,2021
3. Royal College of Physicians, National Lung Cancer Audit (NLCA) annual report 2022 (for the audit period 2019 England, Wales and Guernsey and 2020 England only). https://www.rcplondon.ac.uk/projects/outputs/nlca-annual-report-2022 (accessed November 2023).
4. M.B. Amin, F.L. Greene, S.B. Edge, et al, The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging, CA Cancer J. Clin. 67 (2) (2017) 93–99. 10.3322/caac.21388.
5. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N. Engl. J. Med.,2018